Institute of Molecular Medicine,Peking University,Beijing,100871,P. R. China
This work was supported by grants from The National Natural Science Foundation of China (81402863) and Postdoctoral Science Foundation of China (2014M550008)
Asialoglycoprotein receptor (ASGPR) was specifically expressed by hepatocytes, which could recognize and bind asialoglycoprotein, galactose (Gal), galactosamine, N-acetylgalactosamine (GalNAc), etc. with high affinity. In a receptor-mediated-endocytosis (RME) manner, various molecules could be delivered into hepatocytes effectively. In this review, we firstly introduced the discovery, structure, function, expression pattern and endocytosis properties of ASGPR. Then the influence factors of ligand/receptor interaction and RME, including ligand species, valence, orientation and particle size, were analyzed. In addition, studies on ASGPR-mediated drug delivery in the past decades were reviewed. More importantly, progress in GalNAc-conjugation or -modification technologies employed in liver-targeted transportation of siRNA, antisense and antagomir were summarized.
HUANG Yuan-Yu, LIANG Zi-Cai. Asialoglycoprotein Receptor and Its Application in Liver-targeted Drug Delivery[J]. Progress in Biochemistry and Biophysics,2015,42(6):501-510
Copy® 2025 All Rights Reserved ICP:京ICP备05023138号-1 京公网安备 11010502031771号